Northrop Grumman

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

Last month, during a forum organized by US News & World Report, Amy Caro, vice president of health IT programs at Northrop

Northrop Grumman received the award under the BioWatch Gen-3 System Performance Demonstration Contract, and said that the contract could be worth up to $37 million over three years.

Agilent Technologies, Columbia University, and others are collaborating on development of the system, which will be based on MassTag PCR.

The firms won grants to develop integrated diagnostic systems used to counter natural or man-made biological threats.

The companies will use Luminex's xMAP technology to develop an automated biothreat detection tool for a US biosecurity network.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.